$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2017-08-21 AccNo: 0001193125-17-262763 Size: 34 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接